- Home
- MNTK vs DRTS Comparison
MNTK vs DRTS Comparison
Compare MNTK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- DRTS
- Stock Information
- Founded
- MNTK 1980
- DRTS 2015
- Country
- MNTK United States
- DRTS Israel
- Employees
- MNTK N/A
- DRTS N/A
- Industry
- MNTK Natural Gas Distribution
- DRTS Medical/Dental Instruments
- Sector
- MNTK Utilities
- DRTS Health Care
- Exchange
- MNTK Nasdaq
- DRTS Nasdaq
- Market Cap
- MNTK 288.8M
- DRTS 300.2M
- IPO Year
- MNTK 2021
- DRTS N/A
- Fundamental
- Price
- MNTK $2.35
- DRTS $4.20
- Analyst Decision
- MNTK Hold
- DRTS Strong Buy
- Analyst Count
- MNTK 3
- DRTS 1
- Target Price
- MNTK $3.33
- DRTS $9.00
- AVG Volume (30 Days)
- MNTK 164.3K
- DRTS 60.0K
- Earning Date
- MNTK 11-05-2025
- DRTS 11-18-2025
- Dividend Yield
- MNTK N/A
- DRTS N/A
- EPS Growth
- MNTK N/A
- DRTS N/A
- EPS
- MNTK 0.02
- DRTS N/A
- Revenue
- MNTK $181,341,000.00
- DRTS N/A
- Revenue This Year
- MNTK $2.89
- DRTS N/A
- Revenue Next Year
- MNTK $19.36
- DRTS N/A
- P/E Ratio
- MNTK $125.71
- DRTS N/A
- Revenue Growth
- MNTK N/A
- DRTS N/A
- 52 Week Low
- MNTK $1.68
- DRTS $2.14
- 52 Week High
- MNTK $6.04
- DRTS $4.69
- Technical
- Relative Strength Index (RSI)
- MNTK 58.33
- DRTS 56.64
- Support Level
- MNTK $2.10
- DRTS $3.97
- Resistance Level
- MNTK $2.29
- DRTS $4.34
- Average True Range (ATR)
- MNTK 0.14
- DRTS 0.28
- MACD
- MNTK 0.01
- DRTS -0.01
- Stochastic Oscillator
- MNTK 91.78
- DRTS 64.29
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.